Global Parallel Artificial Membrane Permeability Assay Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062506245

Publication Date:

June 23, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Parallel Artificial Membrane Permeability Assay market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput screening method used in drug discovery to predict the passive permeability of a compound across biological membranes. It is a cost-effective and rapid alternative to traditional in vitro permeability assays.
PAMPA involves the use of an artificial lipid membrane, typically made of a phospholipid bilayer, which mimics the properties of biological membranes. The compound of interest is applied to one side of the membrane, and the rate at which it crosses the membrane is measured. The rate of permeation is determined by factors such as the compound"s lipophilicity, molecular size, and charge.
The PAMPA assay can be performed in a parallel format, allowing multiple compounds to be tested simultaneously. It is commonly used in early stages of drug discovery to assess the potential for a compound to be absorbed into the bloodstream, cross the blood-brain barrier, or penetrate other biological barriers.
The results obtained from PAMPA can be used to prioritize compounds for further testing and optimization, as well as to estimate the bioavailability and pharmacokinetic properties of a compound.

This report is a detailed and comprehensive analysis for global Parallel Artificial Membrane Permeability Assay market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Parallel Artificial Membrane Permeability Assay market size and forecasts, in consumption value ($ Million), 2020-2031
Global Parallel Artificial Membrane Permeability Assay market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Parallel Artificial Membrane Permeability Assay market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Parallel Artificial Membrane Permeability Assay market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parallel Artificial Membrane Permeability Assay
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parallel Artificial Membrane Permeability Assay market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cyprotex, Creative Biolabs, Admescope, Creative Bioarray, Enamine, Sygnature Discovery, Aurigene Pharmaceutical Services, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Parallel Artificial Membrane Permeability Assay market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Caco-2 Cultures
Gastrointestinal Tract
Blood鈥揵rain Barrier
Skin
Market segment by Application
Drug Discovery
Cosmetic Research
Toxicology Research
Drug Delivery Research
Market segment by players, this report covers
Cyprotex
Creative Biolabs
Admescope
Creative Bioarray
Enamine
Sygnature Discovery
Aurigene Pharmaceutical Services
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Parallel Artificial Membrane Permeability Assay product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parallel Artificial Membrane Permeability Assay, with revenue, gross margin, and global market share of Parallel Artificial Membrane Permeability Assay from 2020 to 2025.
Chapter 3, the Parallel Artificial Membrane Permeability Assay competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Parallel Artificial Membrane Permeability Assay market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parallel Artificial Membrane Permeability Assay.
Chapter 13, to describe Parallel Artificial Membrane Permeability Assay research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parallel Artificial Membrane Permeability Assay by Type
1.3.1 Overview: Global Parallel Artificial Membrane Permeability Assay Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Parallel Artificial Membrane Permeability Assay Consumption Value Market Share by Type in 2024
1.3.3 Caco-2 Cultures
1.3.4 Gastrointestinal Tract
1.3.5 Blood鈥揵rain Barrier
1.3.6 Skin
1.4 Global Parallel Artificial Membrane Permeability Assay Market by Application
1.4.1 Overview: Global Parallel Artificial Membrane Permeability Assay Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug Discovery
1.4.3 Cosmetic Research
1.4.4 Toxicology Research
1.4.5 Drug Delivery Research
1.5 Global Parallel Artificial Membrane Permeability Assay Market Size & Forecast
1.6 Global Parallel Artificial Membrane Permeability Assay Market Size and Forecast by Region
1.6.1 Global Parallel Artificial Membrane Permeability Assay Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Parallel Artificial Membrane Permeability Assay Market Size by Region, (2020-2031)
1.6.3 North America Parallel Artificial Membrane Permeability Assay Market Size and Prospect (2020-2031)
1.6.4 Europe Parallel Artificial Membrane Permeability Assay Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Parallel Artificial Membrane Permeability Assay Market Size and Prospect (2020-2031)
1.6.6 South America Parallel Artificial Membrane Permeability Assay Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Parallel Artificial Membrane Permeability Assay Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Cyprotex
2.1.1 Cyprotex Details
2.1.2 Cyprotex Major Business
2.1.3 Cyprotex Parallel Artificial Membrane Permeability Assay Product and Solutions
2.1.4 Cyprotex Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Cyprotex Recent Developments and Future Plans
2.2 Creative Biolabs
2.2.1 Creative Biolabs Details
2.2.2 Creative Biolabs Major Business
2.2.3 Creative Biolabs Parallel Artificial Membrane Permeability Assay Product and Solutions
2.2.4 Creative Biolabs Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Creative Biolabs Recent Developments and Future Plans
2.3 Admescope
2.3.1 Admescope Details
2.3.2 Admescope Major Business
2.3.3 Admescope Parallel Artificial Membrane Permeability Assay Product and Solutions
2.3.4 Admescope Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Admescope Recent Developments and Future Plans
2.4 Creative Bioarray
2.4.1 Creative Bioarray Details
2.4.2 Creative Bioarray Major Business
2.4.3 Creative Bioarray Parallel Artificial Membrane Permeability Assay Product and Solutions
2.4.4 Creative Bioarray Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Creative Bioarray Recent Developments and Future Plans
2.5 Enamine
2.5.1 Enamine Details
2.5.2 Enamine Major Business
2.5.3 Enamine Parallel Artificial Membrane Permeability Assay Product and Solutions
2.5.4 Enamine Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Enamine Recent Developments and Future Plans
2.6 Sygnature Discovery
2.6.1 Sygnature Discovery Details
2.6.2 Sygnature Discovery Major Business
2.6.3 Sygnature Discovery Parallel Artificial Membrane Permeability Assay Product and Solutions
2.6.4 Sygnature Discovery Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sygnature Discovery Recent Developments and Future Plans
2.7 Aurigene Pharmaceutical Services
2.7.1 Aurigene Pharmaceutical Services Details
2.7.2 Aurigene Pharmaceutical Services Major Business
2.7.3 Aurigene Pharmaceutical Services Parallel Artificial Membrane Permeability Assay Product and Solutions
2.7.4 Aurigene Pharmaceutical Services Parallel Artificial Membrane Permeability Assay Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Parallel Artificial Membrane Permeability Assay Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Parallel Artificial Membrane Permeability Assay by Company Revenue
3.2.2 Top 3 Parallel Artificial Membrane Permeability Assay Players Market Share in 2024
3.2.3 Top 6 Parallel Artificial Membrane Permeability Assay Players Market Share in 2024
3.3 Parallel Artificial Membrane Permeability Assay Market: Overall Company Footprint Analysis
3.3.1 Parallel Artificial Membrane Permeability Assay Market: Region Footprint
3.3.2 Parallel Artificial Membrane Permeability Assay Market: Company Product Type Footprint
3.3.3 Parallel Artificial Membrane Permeability Assay Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Parallel Artificial Membrane Permeability Assay Consumption Value and Market Share by Type (2020-2025)
4.2 Global Parallel Artificial Membrane Permeability Assay Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Parallel Artificial Membrane Permeability Assay Consumption Value Market Share by Application (2020-2025)
5.2 Global Parallel Artificial Membrane Permeability Assay Market Forecast by Application (2026-2031)
6 North America
6.1 North America Parallel Artificial Membrane Permeability Assay Consumption Value by Type (2020-2031)
6.2 North America Parallel Artificial Membrane Permeability Assay Market Size by Application (2020-2031)
6.3 North America Parallel Artificial Membrane Permeability Assay Market Size by Country
6.3.1 North America Parallel Artificial Membrane Permeability Assay Consumption Value by Country (2020-2031)
6.3.2 United States Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
6.3.3 Canada Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
6.3.4 Mexico Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Parallel Artificial Membrane Permeability Assay Consumption Value by Type (2020-2031)
7.2 Europe Parallel Artificial Membrane Permeability Assay Consumption Value by Application (2020-2031)
7.3 Europe Parallel Artificial Membrane Permeability Assay Market Size by Country
7.3.1 Europe Parallel Artificial Membrane Permeability Assay Consumption Value by Country (2020-2031)
7.3.2 Germany Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
7.3.3 France Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
7.3.5 Russia Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
7.3.6 Italy Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Parallel Artificial Membrane Permeability Assay Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Parallel Artificial Membrane Permeability Assay Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Parallel Artificial Membrane Permeability Assay Market Size by Region
8.3.1 Asia-Pacific Parallel Artificial Membrane Permeability Assay Consumption Value by Region (2020-2031)
8.3.2 China Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8.3.3 Japan Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8.3.4 South Korea Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8.3.5 India Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
8.3.7 Australia Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
9 South America
9.1 South America Parallel Artificial Membrane Permeability Assay Consumption Value by Type (2020-2031)
9.2 South America Parallel Artificial Membrane Permeability Assay Consumption Value by Application (2020-2031)
9.3 South America Parallel Artificial Membrane Permeability Assay Market Size by Country
9.3.1 South America Parallel Artificial Membrane Permeability Assay Consumption Value by Country (2020-2031)
9.3.2 Brazil Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
9.3.3 Argentina Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Parallel Artificial Membrane Permeability Assay Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Parallel Artificial Membrane Permeability Assay Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Parallel Artificial Membrane Permeability Assay Market Size by Country
10.3.1 Middle East & Africa Parallel Artificial Membrane Permeability Assay Consumption Value by Country (2020-2031)
10.3.2 Turkey Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
10.3.4 UAE Parallel Artificial Membrane Permeability Assay Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Parallel Artificial Membrane Permeability Assay Market Drivers
11.2 Parallel Artificial Membrane Permeability Assay Market Restraints
11.3 Parallel Artificial Membrane Permeability Assay Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Parallel Artificial Membrane Permeability Assay Industry Chain
12.2 Parallel Artificial Membrane Permeability Assay Upstream Analysis
12.3 Parallel Artificial Membrane Permeability Assay Midstream Analysis
12.4 Parallel Artificial Membrane Permeability Assay Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Cyprotex
Creative Biolabs
Admescope
Creative Bioarray
Enamine
Sygnature Discovery
Aurigene Pharmaceutical Services

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂